BioCryst Pharmaceuticals, Inc. (BCRX)
8.90
+0.07
(+0.79%)
USD |
NASDAQ |
May 07, 16:00
9.02
+0.12
(+1.35%)
Pre-Market: 08:59
BioCryst Pharmaceuticals Shareholders Equity (Quarterly) : -553.84M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 133.90M |
| KalVista Pharmaceuticals, Inc. | -2.711M |
| Lantheus Holdings, Inc. | 1.090B |
| Revolution Medicines, Inc. | 1.631B |
| Plus Therapeutics, Inc. | 3.996M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 465.05M |
| Debt to Equity Ratio | -1.522 |
| Current Ratio | 2.062 |
| Net Debt Paydown Yield | -0.01% |